Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Alliance Grants

The University of British Columbia

$56,700.00

Identifying the biosynthetic pathways for pharmaceutical alkaloids in Mitragyna species

EF 2024-25

Résumé
The leaves of the ethnobotanically important plant Mitragyna speciosa (kratom) produce over 50 monoterpene indole alkaloids (MIAs) and spirooxindole alkaloids, structurally complex and distinct compounds with diverse pharmaceutical applications with unknown biosynthetic pathways as well as ecophysiological roles. Notably, MIA mitragynine has demonstrated potential as a therapeutic agent for pain management, opioid use disorder, and opioid withdrawal, and spirooxindole mitraphylline exhibits significant anti-tumor activity. However, the substantial knowledge gap in the biosynthesis of these bioactive alkaloids in M. speciosa impedes our understanding of the metabolic networks and biocatalytic mechanisms underlying chemical diversity in kratom and related species, hinders the engineering and production of these high-value compounds, and creates a bottleneck in pharmaceutical research and development. This proposal harnesses the expertise of an international and interdisciplinary team to elucidate the biosynthetic pathways of multiple bioactive alkaloids in Mitragyna species. Employing a multifaceted approach that integrates genomics, transcriptomics, and metabolomics, the project aims to (1) generate comprehensive genomic resources for Mitragyna species, (2) fully elucidate the biosynthesis of the two key MIAs mitragynine and speciogynine and (3) elucidate the biosynthesis of the anticancer spirooxindole mitraphylline and its related compounds. Key deliverables of this project include the detailed elucidation of biosynthetic pathways for pharmaceutically significant MIAs-mitragynine, speciogynine, and the spirooxindole alkaloid mitraphylline. Genome-wide polymorphism analysis across Mitragyna species will facilitate the identification of M. speciosa chemotypes, aiding in cultivar development and promoting high-value agriculture in Canada and the US. The successful identification of biosynthetic enzymes through this project will enable the development of robust production platforms for systematic pharmacological studies of individual alkaloids.
Programme
Alliance Grants
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
597402-2024
Name nom
Dang, Thu Thuy T
Department département
Okanagan - Chemistry
Organization id
2
Institution établissement
The University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
56700
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Identifying the biosynthetic pathways for pharmaceutical alkaloids in Mitragyna species
Keywords
alkaloids; anticancer; biocatalysts; enzymes; omics; opiod use disorder; pain; pharmaceuticals; plant specialized metabolism; synthetic biology
Application summary
The leaves of the ethnobotanically important plant Mitragyna speciosa (kratom) produce over 50 monoterpene indole alkaloids (MIAs) and spirooxindole alkaloids, structurally complex and distinct compounds with diverse pharmaceutical applications with unknown biosynthetic pathways as well as ecophysiological roles. Notably, MIA mitragynine has demonstrated potential as a therapeutic agent for pain management, opioid use disorder, and opioid withdrawal, and spirooxindole mitraphylline exhibits significant anti-tumor activity. However, the substantial knowledge gap in the biosynthesis of these bioactive alkaloids in M. speciosa impedes our understanding of the metabolic networks and biocatalytic mechanisms underlying chemical diversity in kratom and related species, hinders the engineering and production of these high-value compounds, and creates a bottleneck in pharmaceutical research and development. This proposal harnesses the expertise of an international and interdisciplinary team to elucidate the biosynthetic pathways of multiple bioactive alkaloids in Mitragyna species. Employing a multifaceted approach that integrates genomics, transcriptomics, and metabolomics, the project aims to (1) generate comprehensive genomic resources for Mitragyna species, (2) fully elucidate the biosynthesis of the two key MIAs mitragynine and speciogynine and (3) elucidate the biosynthesis of the anticancer spirooxindole mitraphylline and its related compounds. Key deliverables of this project include the detailed elucidation of biosynthetic pathways for pharmaceutically significant MIAs-mitragynine, speciogynine, and the spirooxindole alkaloid mitraphylline. Genome-wide polymorphism analysis across Mitragyna species will facilitate the identification of M. speciosa chemotypes, aiding in cultivar development and promoting high-value agriculture in Canada and the US. The successful identification of biosynthetic enzymes through this project will enable the development of robust production platforms for systematic pharmacological studies of individual alkaloids.